Ⅲ期恶性黑色素瘤患者术后辅助抗PD-1 vs 靶向治疗：中国多中心真实世界数据分析
李婷, 徐宇, 贾东东, 廖智超, 孙伟, 吴海啸, 任志午, 赵军, 邢汝维, 滕胜, 杨蕴, 陈勇, 李涛, 杨吉龙
Adjuvant therapy with anti-PD-1 antibody vs targeted therapy for patients with resected stage Ⅲ malignant melanoma: a real-world data analysis from China centers
LI Ting, XU Yu, JIA Dongdong, LIAO Zhichao, SUN Wei, WU Haixiao, REN Zhiwu, ZHAO Jun, XING Ruwei, TENG Sheng, YANG Yun, CHEN Yong, LI Tao, YANG Jilong
中国癌症杂志
.
2022, (12): 1147
-1157
.
DOI: 10.19401/j.cnki.1007-3639.2022.12.002
